| |
All patients n (%)
|
Groups
|
|---|
| | | | |
A (n = 84)
| |
B (n = 114)
| | |
|---|
| |
Dead
|
Alive
|
P
|
Dead
|
Alive
|
Total
|
Dead
|
Alive
|
Total
|
P
|
|---|
| |
86 (43.4)
|
112 (56.6)
| |
31 (36.1)
|
53 (63.9)
|
84
|
55 (48.2)
|
59 (51.8)
|
114
|
0.112
|
|
Age
| | | | | | | | | |
0.112
|
| ≦60 |
50 (38.5)
|
80 (61.5)
|
0.052
|
11 (24.4)
|
34 (75.6)
|
45
|
39 (45.9)
|
46 (51.4)
|
85
|
0.017
|
|
> 60
|
36 (52.9)
|
32 (47.1)
|
20 (51.3)
|
19 (48.7)
|
39
|
16 (55.2)
|
19 (48.7)
|
39
|
0.752
|
|
Gender
| | | | | | | | | |
0.112
|
|
Female
|
22 (40.7)
|
32 (59.3)
|
0.640
|
9 (40.9)
|
13 (59.1)
|
22
|
13 (40.6)
|
19 (59.4)
|
32
|
0.983
|
|
Male
|
64 (44.4)
|
80 (55.6)
|
22 (35.5)
|
40 (64.5)
|
62
|
42 (51.2)
|
40 (48.8)
|
82
|
0.061
|
|
Diabetes
| | | | | | | | | |
0.112
|
|
No
|
48 (37.8)
|
79 (62.2)
|
0.033
|
18 (30.0)
|
42 (70.0)
|
60
|
30 (44.8)
|
37 (55.2)
|
67
|
0.088
|
|
Yes
|
38 (53.5)
|
33 (46.5)
|
13 (54.2)
|
11 (45.8)
|
24
|
25 (53.2)
|
22 (46.8)
|
47
|
0.938
|
|
GCS
| | |
<0.001
| | | | | | |
0.147
|
|
15-13 grade 1
|
3 (10.0)
|
27 (90.0)
| |
0 (0.0)
|
17 (100.0)
|
17
|
3 (23.1)
|
10 (76.9)
|
13
|
0.070
|
|
12-7 grade 2
|
29 (33.0)
|
59 (67.0)
|
0.017a
|
8 (21.6)
|
29 (78.4)
|
37
|
21 (41.2)
|
30 (58.8)
|
51
|
0.055
|
|
6-3 grade 3
|
54 (67.5)
|
26 (32.5)
|
<0.001b
|
23 (76.7)
|
7 (23.3)
|
30
|
31 (62.0)
|
19 (38.0)
|
50
|
0.178
|
|
NIHSS
| | |
<0.001
| | | | | | |
0.147
|
|
<15 grade 1
|
5 (15.6)
|
27 (84.4)
| |
0 (0.0)
|
17 (100.0)
|
17
|
5 (33.3)
|
10 (66.7)
|
15
|
0.015
|
|
15-20 grade 2
|
14 (28.0)
|
36 (72.0)
|
0.284a
|
4 (18.2)
|
18 (81.8)
|
22
|
10 (35.7)
|
18 (64.3)
|
28
|
0.175
|
|
>20 grade 3
|
67 (57.8)
|
49 (42.2)
|
<0.001b
|
27 (60.0)
|
18 (40.0)
|
45
|
40 (56.3)
|
31 (43.7)
|
71
|
0.698
|
|
HV, mL
| | | | | | | | | |
0.112
|
| ≦60 |
41 (31.3)
|
90 (68.7)
|
<0.001
|
13 (21.3)
|
48 (78.7)
|
61
|
28 (40.0)
|
42 (60.0)
|
70
|
0.022
|
|
> 60
|
45 (67.2)
|
22 (32.8)
|
18 (78.3)
|
5 (21.7)
|
23
|
27 (61.4)
|
17 (38.6)
|
44
|
0.165
|
|
IVH
| | |
<0.001
| | | | | | |
0.147
|
|
0
|
16 (25.0)
|
48 (75.0)
|
0.918c
|
3 (10.0)
|
27 (90.0)
|
30
|
13 (38.2)
|
21 (61.8)
|
34
|
0.010
|
|
1-4
|
16 (25.8)
|
46 (74.2)
|
5 (18.5)
|
22 (81.5)
|
27
|
11 (31.4)
|
24 (68.6)
|
35
|
0.253
|
|
5-8
|
27 (75.0)
|
9 (25.0)
|
<0.001a
|
11 (73.3)
|
4 (26.7)
|
15
|
16 (76.2)
|
5 (23.8)
|
21
|
1.000
|
|
9-12
|
27 (75.0)
|
9 (25.0)
|
1.000b
|
12 (100.0)
|
0 (0.0)
|
12
|
15 (62.5)
|
9 (37.5)
|
24
|
0.036
|
|
Complications, n (%)
| | | | | | | | | |
|
RB
| | | | | | | | | |
0.147
|
|
No
|
79 (41.8)
|
110 (58.2)
|
0.042
|
30 (36.1)
|
53 (63.9)
|
83
|
49 (46.2)
|
57 (53.8)
|
106
|
0.164
|
|
Yes
|
7 (77.8)
|
2 (22.2)
|
1 (100.0)
|
0
|
1
|
6 (75.0)
|
2 (25.0)
|
8
|
1.000
|
|
RF
| | | | | | | | | |
0.147
|
|
NO
|
68 (38.4)
|
109 (61.6)
|
<0.001
|
26 (32.9)
|
53 (67.1)
|
79
|
42 (42.9)
|
56 (57.1)
|
98
|
0.177
|
|
Yes
|
18 (85.7)
|
3 (14.3)
| |
5 (100.0)
|
0
|
5
|
13 (81.3)
|
3 (18.8)
|
16
|
0.549
|
|
PI
| | | | | | | | | |
0.147
|
|
No
|
38 (32.8)
|
78 (67.2)
|
<0.001
|
13 (26.0)
|
37 (74.0)
|
50
|
25 (37.9)
|
41 (62.1)
|
66
|
0.179
|
|
Yes
|
48 (58.5)
|
34 (41.5)
| |
18 (52.9)
|
16 (47.1)
|
34
|
30 (62.5)
|
18 (37.5)
|
48
|
0.496
|
|
UGB
| | | | | | | | |
0.147
|
|
No
|
75 (41.0)
|
108 (59.0)
|
0.027
|
25 (32.5)
|
52 (67.5)
|
77
|
50 (47.2)
|
56 (52.8)
|
106
|
0.046
|
|
Yes
|
11 (73.3)
|
4 (26.7)
|
6 (85.7)
|
1 (14.3)
|
7
|
5 (62.5)
|
3 (37.5)
|
8
|
0.569
|
- P values were calculated using the Wilcoxon or Kruskal-Wallis rank sum tests. Groups: A, minimal invasive puncture and drainage; B, decompressive craniectomy; BP: blood pressure; SPB systolic blood pressure. DBP: diastolic blood pressure. GCS: Glasgow Coma Scale; NIHSS: National Institutes of Health Stroke Scale; HV: hematoma volume; IVH: intraventricular hemorrhage; RB: rebleed; PI: pulmonary infection; RF: renal failure; UGB: upper gastrointestinal bleeding; agrade 1 vs. grade 2; bgrade 2 vs. grade 3; cIVH 0 vs. IVH grade 1.
